|
|
Gene Symbol |
TCF7L2 |
|
Aliases |
TCF-4, TCF4 |
|
Entrez Gene ID |
|
|
Gene Name |
Transcription factor 7 like 2 |
|
Chromosomal Location |
10q25.2-q25.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
NM_030756.5, NM_001146274.2, NM_001146283.2, NM_001146284.2, NM_001146285.1, NM_001146286.2, NM_001198525.2, NM_001198526.2, NM_001198527.2, NM_001198528.2, NM_001198529.2, NM_001198530.1, NM_001198531.2, NM_001349870.2, NM_001349871.1, NM_001363501.1, NM_001367943.1 |
|
e!Ensembl
Gene |
|
|
Transcript |
ENST00000627217, ENST00000369397, ENST00000355717, ENST00000352065, ENST00000369395, ENST00000545257, ENST00000629706, ENST00000346198, ENST00000349937, ENST00000369389, ENST00000637574, ENST00000277945, ENST00000369386, ENST00000466338, ENST00000470254, ENST00000480888, ENST00000534894, ENST00000538897, ENST00000536810, ENST00000355995, ENST00000542695, ENST00000543371 |
|
Protein |
ENSP00000486891, ENSP00000358404, ENSP00000347949, ENSP00000344823, ENSP00000358402, ENSP00000440547, ENSP00000487507, ENSP00000345640, ENSP00000298692, ENSP00000358396, ENSP00000490478, ENSP00000277945, ENSP00000358393, ENSP00000490260, ENSP00000435694, ENSP00000490004, ENSP00000443626, ENSP00000446172, ENSP00000446238, ENSP00000348274, ENSP00000443883, ENSP00000444972
|
|
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0000122 |
Biological process |
Negative regulation of transcription by RNA polymerase II |
IDA |
12799378 |
GO:0001568 |
Biological process |
Blood vessel development |
IMP |
15578569 |
GO:0006355 |
Biological process |
Regulation of transcription, DNA-templated |
IBA |
21873635 |
GO:0006357 |
Biological process |
Regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0006357 |
Biological process |
Regulation of transcription by RNA polymerase II |
IDA |
9727977 |
GO:0007050 |
Biological process |
Cell cycle arrest |
IMP |
12408868 |
GO:0009749 |
Biological process |
Response to glucose |
ISS |
19168596 |
GO:0010909 |
Biological process |
Positive regulation of heparan sulfate proteoglycan biosynthetic process |
IMP |
15853773 |
GO:0031016 |
Biological process |
Pancreas development |
TAS |
18216022 |
GO:0032024 |
Biological process |
Positive regulation of insulin secretion |
IBA |
21873635 |
GO:0032024 |
Biological process |
Positive regulation of insulin secretion |
IMP |
19386626 |
GO:0032092 |
Biological process |
Positive regulation of protein binding |
IDA |
12799378 |
GO:0032350 |
Biological process |
Regulation of hormone metabolic process |
IDA |
15525634 |
GO:0042593 |
Biological process |
Glucose homeostasis |
IBA |
21873635 |
GO:0042593 |
Biological process |
Glucose homeostasis |
IDA |
15525634 |
GO:0043433 |
Biological process |
Negative regulation of DNA-binding transcription factor activity |
IDA |
12799378 |
GO:0043570 |
Biological process |
Maintenance of DNA repeat elements |
IMP |
18755497 |
GO:0044334 |
Biological process |
Canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition |
IMP |
17072303 |
GO:0045444 |
Biological process |
Fat cell differentiation |
IDA |
10937998 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IDA |
12799378, 15525634 |
GO:0045892 |
Biological process |
Negative regulation of transcription, DNA-templated |
IMP |
16532032 |
GO:0045944 |
Biological process |
Positive regulation of transcription by RNA polymerase II |
IDA |
9065401, 19168596 |
GO:0046827 |
Biological process |
Positive regulation of protein export from nucleus |
IMP |
19386626 |
GO:0048625 |
Biological process |
Myoblast fate commitment |
IBA |
21873635 |
GO:0048625 |
Biological process |
Myoblast fate commitment |
IDA |
10937998 |
GO:0048660 |
Biological process |
Regulation of smooth muscle cell proliferation |
IMP |
17122440 |
GO:0050679 |
Biological process |
Positive regulation of epithelial cell proliferation |
IMP |
12408868 |
GO:0051897 |
Biological process |
Positive regulation of protein kinase B signaling |
IMP |
19386626 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IBA |
21873635 |
GO:0060070 |
Biological process |
Canonical Wnt signaling pathway |
IC |
9065401 |
GO:0090090 |
Biological process |
Negative regulation of canonical Wnt signaling pathway |
IMP |
16532032 |
GO:0000790 |
Cellular component |
Nuclear chromatin |
IDA |
19443654 |
GO:0005634 |
Cellular component |
Nucleus |
IBA |
21873635 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
9065401, 16532032, 19386626 |
GO:0005654 |
Cellular component |
Nucleoplasm |
IDA |
19168596 |
GO:0005667 |
Cellular component |
Transcription factor complex |
IBA |
21873635 |
GO:0032993 |
Cellular component |
Protein-DNA complex |
IDA |
14661054 |
GO:0070369 |
Cellular component |
Beta-catenin-TCF7L2 complex |
IDA |
9065401, 9065402 |
GO:0000978 |
Molecular function |
RNA polymerase II proximal promoter sequence-specific DNA binding |
IDA |
19443654 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISM |
19274049 |
GO:0000981 |
Molecular function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
NAS |
19274049 |
GO:0001103 |
Molecular function |
RNA polymerase II repressing transcription factor binding |
IPI |
19443654 |
GO:0003682 |
Molecular function |
Chromatin binding |
IBA |
21873635 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IBA |
21873635 |
GO:0003700 |
Molecular function |
DNA-binding transcription factor activity |
IDA |
9727977 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
11713475, 11713476, 16434966, 16442529, 16569639, 16724116, 17283121, 17873903, 17875931, 18193033, 18772112, 19202075, 19816403, 20126258, 22014570, 22056988, 22304967, 24589551, 28829046, 30833792 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IBA |
21873635 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IDA |
9065401 |
GO:0008013 |
Molecular function |
Beta-catenin binding |
IPI |
12408825, 19443654 |
GO:0008134 |
Molecular function |
Transcription factor binding |
IPI |
16007074 |
GO:0019901 |
Molecular function |
Protein kinase binding |
IPI |
16714285 |
GO:0035257 |
Molecular function |
Nuclear hormone receptor binding |
IPI |
12799378 |
GO:0043565 |
Molecular function |
Sequence-specific DNA binding |
IBA |
21873635 |
GO:0043565 |
Molecular function |
Sequence-specific DNA binding |
IDA |
14661054 |
GO:0043565 |
Molecular function |
Sequence-specific DNA binding |
IMP |
16532032 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IBA |
21873635 |
GO:0044212 |
Molecular function |
Transcription regulatory region DNA binding |
IDA |
20128911 |
GO:0045295 |
Molecular function |
Gamma-catenin binding |
IPI |
14661054 |
GO:0070016 |
Molecular function |
Armadillo repeat domain binding |
IPI |
12408825 |
|
Protein Information |
|
Protein Name |
Transcription factor 7-like 2, HMG box transcription factor 4, T-cell factor 4, T-cell-specific transcription factor 4, hTCF-4, transcription factor 7-like 2 (T-cell specific, HMG-box) |
|
Function |
|
|
|
NP_110383.2, NP_001139746.1, NP_001139755.1, NP_001139756.1, NP_001139757.1, NP_001139758.1, NP_001185454.1, NP_001185455.1, NP_001185456.1, NP_001185457.1, NP_001185458.1, NP_001185459.1, NP_001185460.1, NP_001336799.1, NP_001336800.1, NP_001350430.1, NP_001354872.1
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000263408 |
|
P02748 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Heart Failure |
|
Coronary heart disease |
|
Arteriosclerosis |
|
Atrial Fibrillation |
|
Endocrine System Diseases |
Diabetes Mellitus |
18097733, 17609304, 17245407, 16415884, 17340123, 17470138, 28254843, 17463246, 18372903, 24390345, 19401414, 29358691, 22693455, 17460697, 17668382, 25483131, 23300278, 23209189, 20694148, 19734900, 24509480, 27189021, 28869590, 17293876, 23945395, 26818947, 22885922, 25102180, 175, 27790247 |
PCOS |
|
Immune System Diseases |
Still Disease |
|
Juvenile arthritis |
|
Neoplasms |
Adenocarcinoma |
|
Breast Cancer |
|
Colorectal Cancer |
|
Carcinoma |
|
Cribriform Carcinoma |
|
Colonic Neoplasms |
|
Adenocarcinoma Of Large Intestine |
|
Nervous System Diseases |
Stroke |
|
Nutritional and Metabolic Diseases |
Metabolic Syndrome X |
|
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Schizophrenia |
|
Bipolar Disorder |
|
Schizoaffective Disorder |
|
Neurodevelopmental Disorders |
|
Obstructive Sleep Apnea |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
NCF2,SERPINA1,ITGAX,TAB2,IGF2R,TXNIP |
Diabetes mellitus, inflammation, cardiovascular diseases, and infertility in the granulosa cells,follicular growth arrest and metabolic disorders |
|
|
Related
|
|
Real-time quantitative PCR confirmed higher expression of NCF2 (2.13-fold), TCF7L2 (1.92-fold), and SERPINA1 (5.35-fold). Increased expression of inflammation genes ITGAX (3.68-fold) and TAB2 (1.86-fold) was confirmed in PCOS non-IR |
|
|
Type 2 diabetes,impairment of glucose homeostasis |
SNPs rs11196218 and rs290487 of the TCF7L2 gene |
|
Related
|
Chinese population- 430 PCOS patients and 360 controls |
The data suggests that the TCF7L2 variants may confer an increased risk for early impairment of glucose homeostasis in PCOS |
|
|
Type 2 diabetes mellitus |
58 single nucleotide polymorphisms mapping to TCF7L2(associated SNP's-rs11196236,rs11196229) |
NICHD, Rotterdam, Androgen Excess Society criteria |
Related
|
European ancestry-624 PCOS and 553 control women |
We have observed evidence of association with two independent TCF7L2 loci in a PCOS cohort: |
|
KCNJ11 E23K variants |
Hyperinsulinemia and type 2 diabetes mellitus |
TCF7L2 rs7903146(C/T) |
|
Related
|
Greek population-183 PCOS patients and 148 healthy controls |
These data provide evidence that the rs7903146 variant of the TCF7L2 gene might influence PCOS predisposition, while no association is observed between the E23K variant of KCNJ11 and susceptibility to PCOS and related traits. |
|
|
PCOS |
rs4506565, rs7903146, rs12243326, and rs12255372 |
|
Weak or Unrelated
|
119 Tunisian women with PCOS (mean age 29.8 4.7years), and 150 control women (mean age 30.6 5.9years) |
The data suggest that there is weak or no contribution of TCF7L2 gene polymorphism to PCOS in Tunisian women. Further studies with larger samples are necessary to confirm this observation. |
|
FTO,INSIG2,MC4R |
Chronic anovulation,hyperandrogenism,type 2 diabetes ,insulin resistance and obesity |
SNPs in TCF7L2 |
Rotterdam criteria |
Related
|
|
The TCF7L2 SNP was associated with body weight traits in PCOS women. |
|
FBN3 |
|
rs11196236 |
NIH criteria |
Related
|
European ancestry-31 PCOS and 18 control women |
The study concludes that rs11196236 G TCF7L2 variant is associated with peripheral insulin resistance in PCOS but this effect is not seen in control women. |
|
|
|